Wed, Jul 30, 2014, 6:25 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • system_architect_enterprise system_architect_enterprise Jun 4, 2013 9:43 AM Flag

    Revenue estimates are $30M 2013 & $140M 2014 =$250/share value

    Consensus estimates are for $30M in 2013 and $140M in 2014 which is a growth rate of 466%.
    So while we typically use the growth rate as the multiplier for fair PE we know that 466% is not sustainable, so we can use a more conservative 100 even though the 2015 estimates are still over $500M which is a 357% year over year growth rate.

    So take that $140M and subtract 68M (current annual expenditures, ignoring other income for now) and we arrive at $72M in earnings across 28.8M shares for EPS of $2.50/share. Multiply that by the conservative 100 and it puts us a $250/share as value target in 2014.

    From the current value at $74/share, that is a year over year gain of 344% for this stock from this year until next year. That will be a nice TRIPLE over current valuations and crushes the bashers claiming current prices are inflated. If anything we should be over $100/share right now.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEGR
35.65+5.03(+16.43%)Jul 30 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.